The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
Open accessAbstract
Many patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the aforementioned issues with diagnostic error definitions, most clinical practice guidelines target specific diseases, ignoring their relevance for patients with various comorbidities [148,149,150].”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationBarnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Self-citationBoyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911
Self-citationGRADE guidelines: 8. Rating the quality of evidence—indirectness
Guyatt, G. H., Oxman, A. D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Falck-Ytter, Y., Jaeschke, R., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.04.014 · Cited by 1,843
Self-citationGuyatt, G. H., Akl, E. A., Crowther, M. A., Gutterman, D. D., & Schünemann, H. J. (2012) · CHEST Journal · doi:10.1378/chest.1412s3 · Cited by 1,545
Self-citationPatterns of Functional Decline at the End of Life
Lunney, J. R. (2003) · JAMA · doi:10.1001/jama.289.18.2387 · Cited by 1,418
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
for the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756
Research works printed but not linked: 15
- Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68. · DOI
- Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4. · DOI
- Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.
- Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40. · DOI
- Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610–7. · DOI
- Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011.
- National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005.
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154. · DOI · Paper page
- Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–86. · DOI
- KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130.
- MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S. · DOI
- Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.
- Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012;7(8):e41601. · DOI
- You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.
- Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854–60. · DOI
Cited by
Sorted by citations
Skou, S. T., Mair, F. S., Fortin, M., Guthrie, B., Nunes, B. P., Miranda, J. J., Boyd, C. M., Pati, S., Mtenga, S., & Smith, S. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00376-4 · Cited by 1,499
“Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies (via University of North Carolina at Chapel Hill School of Public Health), FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the NewtonPaulet Fund (223-2018, 224-2018), DFID/ MRC/Wellcome Global Health Trials (MR/M007405/1), Fo…”
MethodSelf-citationAdler, R. A., Fuleihan, G. E., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J.-A., Favus, M. J., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 689
“As has been discussed in a series of papers on guidelines,((146)) basing guidelines on randomized trials does not address the impact of coexisting conditions in many patients with a given disorder.”
The multimorbidity interaction severity index (MISI)
Gassmann, D., Cheetham, M., Siebenhuener, K., Holzer, B. M., Meindl-Fridez, C., Hildenbrand, F. F., Virgini, V. S., Martin, M., & Battegay, E. J. (2017) · Medicine · doi:10.1097/md.0000000000006144 · Cited by 8
Multimorbidity and quality of life: Systematic literature review and meta-analysis
Makovski, T. T., Schmitz, S., Zeegers, M. P., Stranges, S., & van den Akker, M. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.04.005 · Cited by 722
“Health care systems are still largely single disease oriented and lack clinical guidelines for multimorbidity (Barnett et al., 2012a; Salisbury et al., 2011; Uhlig et al., 2014).”
Fabbri, E., Zoli, M., González‐Freire, M., Salive, M. E., Studenski, S. A., & Ferrucci, L. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.013 · Cited by 589
Multimorbidity in Older Adults With Cardiovascular Disease
Forman, D. E., Maurer, M. S., Boyd, C., Brindis, R., Salive, M. E., Horne, F. M., Bell, S. P., Fulmer, T., Reuben, D. B., Zieman, S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.022 · Cited by 484
“, statins for primary prevention, such that the time required for anticipated benefit may exceed the remaining lifespan in someone with an end-stage disease) (20).”
BackgroundSelf-citationDumbreck, S., Flynn, A., Nairn, M., Wilson, M., Treweek, S. P., Mercer, S. W., Alderson, P., Thompson, A., Payne, K., & Guthrie, B. (2015) · BMJ · doi:10.1136/bmj.h949 · Cited by 347
Multimorbidity: What Do We Know? What Should We Do?
Navickas, R., Petric, V.-K., Feigl, A. B., & Seychell, M. (2016) · Journal of Comorbidity · doi:10.15256/joc.2016.6.72 · Cited by 300
Decision aids that really promote shared decision making: the pace quickens
Agoritsas, T., Heen, A. F., Brandt, L., Alonso‐Coello, P., Kristiansen, A., Akl, E. A., Neumann, I., Tikkinen, K. A. O., van der Weijden, T., Elwyn, G. J., et al. (2015) · BMJ · doi:10.1136/bmj.g7624 · Cited by 266
Self-citationSt Sauver, J. L., Boyd, C. M., Grossardt, B. R., Bobo, W. V., Finney Rutten, L. J., Roger, V. L., Ebbert, J. O., Therneau, T. M., Yawn, B. P., & Rocca, W. A. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006413 · Cited by 257
Self-citationTinetti, M. E., Naik, A. D., Dindo, L. N., Costello, D. M., Esterson, J., Geda, M. E., Rosen, J. D., Hernandez‐Bigos, K., Smith, C. D., Ouellet, G. M., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.4235 · Cited by 284
Boyd, C. M., Smith, C. D., Masoudi, F. A., Blaum, C. S., Dodson, J. A., Green, A. R., Kelley, A. S., Matlock, D. D., Ouellet, J. A., Rich, M. W., et al. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15809 · Cited by 330
Self-citationThe SELFIE framework for integrated care for multi-morbidity: Development and description
Leijten, F., Struckmann, V., van Ginneken, E., Czypionka, T., Kraus, M., Reiss, M., Tsiachristas, A., Boland, M. R. S., Bont, A. A. D., Bal, R. A., et al. (2017) · Health Policy · doi:10.1016/j.healthpol.2017.06.002 · Cited by 263
“NICE guideline; 2016.”
BackgroundArnett, D. K., Goodman, R. A., Halperin, J. L., Anderson, J. L., Parekh, A. K., & Zoghbi, W. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.012 · Cited by 171
“This issue is particularly important for some older adults, because clinicians must select from among treatments on the basis of evidence for risk and benefit (9).”
BackgroundThe Association Between Multimorbidity and Quality of Life, Health Status and Functional Disability
Williams, J. S., & Egede, L. E. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.03.004 · Cited by 194
“Similarly, those with SPD were significantly more limited in ADLs (8.95 versus 1.46; P o 0.0001), IADLs (13.05 versus 2.52; P o 0.0001) and physical functioning (37.65 versus 10.57; P o 0.0001) compared to those without SPD. Table 4 shows the logistic regression models for the functional limitation outcomes by MM.”
BackgroundInfluentialRelevant models and elements of integrated care for multi-morbidity: Results of a scoping review
Struckmann, V., Leijten, F., van Ginneken, E., Kraus, M., Reiss, M., Spranger, A., Boland, M. R. S., Czypionka, T., Busse, R., & Mölken, M. R. (2017) · Health Policy · doi:10.1016/j.healthpol.2017.08.008 · Cited by 174
Patient Priority–Directed Decision Making and Care for Older Adults with Multiple Chronic Conditions
Tinetti, M. E., Esterson, J., Ferris, R. E., Posner, P., & Blaum, C. S. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.01.012 · Cited by 145
Multiple chronic conditions and healthcare costs among adults
Sambamoorthi, U., Tan, X., & Deb, A. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2015.1091730 · Cited by 144
“[17] also proposed a framework to help develop clinical practice guidelines for the care and management of people with MCC.”
BackgroundOutcome Goals and Health Care Preferences of Older Adults With Multiple Chronic Conditions
Tinetti, M. E., Costello, D. M., Naik, A. D., Davenport, C., Hernandez‐Bigos, K., Liew, J. R., Esterson, J., Kiwak, E., & Dindo, L. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1271 · Cited by 127
“of chronic conditions, median (IQR) 4 (3-5) Prescription medications usedd”
BackgroundMultimorbidity in Older Patients with Cardiovascular Disease
Dunlay, S. M., & Chamberlain, A. M. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0491-8 · Cited by 119
Paci, M., Faedda, G., Ugolini, A., & Pellicciari, L. (2021) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzab093 · Cited by 132
Arnett, D. K., Goodman, R. A., Halperin, J. L., Anderson, J. L., Parekh, A. K., & Zoghbi, W. A. (2014) · Circulation · doi:10.1161/cir.0000000000000128 · Cited by 225
“This issue is particularly important for some older adults, because clinicians must select from among treatments on the basis of evidence for risk and benefit.(9)”
BackgroundWalker, E. R., & Druss, B. G. (2017) · Psychology, Health & Medicine · doi:10.1080/13548506.2016.1227855 · Cited by 98
“Recently, work has been done to examine measurement of multimorbidities (Diederichs, Berger, & Bartels, 2011) and generate guidelines and recommendations for improving the health of people with multiple medical conditions (Uhlig et al., 2014).”
BackgroundQuality of care assessment for people with multimorbidity
Valderas, J. M., Gangannagaripalli, J., Nolte, E., Boyd, C. M., Roland, M. O., Sarría‐Santamera, A., Jones, E., & Rijken, M. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12881 · Cited by 102
Self-citationDistinguishing Comorbidity, Disability, and Frailty
Espinoza, S. E., Quiben, M., & Hazuda, H. P. (2018) · Current Geriatrics Reports · doi:10.1007/s13670-018-0254-0 · Cited by 94
Applying clinical guidelines in general practice: a qualitative study of potential complications
Austad, B., Hetlevik, I., Mjølstad, B. P., & Helvik, A. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0490-3 · Cited by 78
“Clinical guidelines build on EBM and are most often designed to treat single diseases or risk factors [43].”
BackgroundTinetti, M. E., Dindo, L. N., Smith, C. D., Blaum, C. S., Costello, D. M., Ouellet, G. M., Rosen, J. D., Hernandez‐Bigos, K., Geda, M. E., & Naik, A. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218249 · Cited by 78
Choudhury, A., Renjilian, E., & Asan, O. (2020) · JAMIA Open · doi:10.1093/jamiaopen/ooaa034 · Cited by 94
Tinetti, M. E., McAvay, G., Trentalange, M., Cohen, A. B., & Allore, H. G. (2015) · BMJ · doi:10.1136/bmj.h4984 · Cited by 58
Multimorbidity and Evidence Generation
Weiss, C. O., Varadhan, R., Puhan, M. A., Vickers, A. J., Bandeen‐Roche, K., Boyd, C. M., & Kent, D. M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2660-5 · Cited by 73
“Here, we focus on improving the generation, analysis and reporting of primary data, while companion papers discuss evidence synthesis and integration,(4) and the development of CPG recommendations themselves.(5)”
Self-citationLim, C. Y., Berry, A. B. L., Hirsch, T., Hartzler, A. L., Wagner, E. H., Ludman, E. J., & Ralston, J. D. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4154-3 · Cited by 76
Chronic obstructive pulmonary disease comorbidities
Brown, J. P., & Martinez, C. (2016) · Current opinion in pulmonary medicine · doi:10.1097/mcp.0000000000000241 · Cited by 67
“Persisting challenges include the implementation of this knowledge in clinical practice, for the design of clinical trials based on the identified clusters of comorbidities, and to tailor treatment guidelines into a more personalized but still practical approach [74,75].”
BackgroundNelson, M. L. A., McKellar, K. A., Yi, J., Kelloway, L., Munce, S., Cott, C. A., Hall, R., Fortin, M., Teasell, R. W., & Lyons, R. (2017) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2017.1282412 · Cited by 63
Facilitating Self-reflection about Values and Self-care Among Individuals with Chronic Conditions
Lim, C. Y., Berry, A. B. L., Hartzler, A. L., Hirsch, T., Carrell, D., Bermet, Z. A., & Ralston, J. D. (2019) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3290605.3300885 · Cited by 48
“To improve the quality of healthcare for individuals with MCC, the importance of orienting care around patients’ values is well-documented [6, 39].”
BackgroundNothelle, S. K., Sharma, R., Oakes, A. H., Jackson, M., & Segal, J. B. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.005 · Cited by 68
Roberge, P., Hudon, C., Pavilanis, A., Beaulieu, M., Benoît, A., Brouillet, H., Boulianne, I., Pauw, A. D., Frigon, S., Gaboury, I., et al. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0531-y · Cited by 75
“To compound the problem, there is often a lack of explicit guidance with regards to multimorbidity in clinical practice guidelines [46].”
BackgroundMultimorbidity: Implications and directions for health psychology and behavioral medicine.
Suls, J., Green, P. A., & Boyd, C. M. (2019) · Health Psychology · doi:10.1037/hea0000762 · Cited by 52
“For example, depression commonly occurs with diabetes (Nouwen et al., 2010; Uhlig et al., 2014)).”
BackgroundSelf-citationAssociation of Multimorbidity with Mortality and Healthcare Utilization in Chronic Kidney Disease
Bowling, C. B., Plantinga, L., Phillips, L. S., McClellan, W., Echt, K. V., Chumbler, N. R., McGwin, G., Vandenberg, A. E., Allman, R. M., & Johnson, T. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14662 · Cited by 55
“NSAIDs is prioritized over reducing risk of CKD progression, patients may be at increased risk of acute kidney injury or worsening hypertension.(6,7) The presence of concordant conditions may increase the likelihood of achieving chronic disease management goals as has been shown in diabetes.”
BackgroundMethodInfluentialWilson, K. C., Gould, M. K., Krishnan, J. A., Boyd, C. M., Brożek, J., Cooke, C. R., Douglas, I. S., Goodman, R. A., Joo, M. J., Lareau, S. C., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201601-007st · Cited by 18
“Finally, guidelines can address multimorbidity in a non–disease-specific way, such as guidelines addressing the coordination of care or self-management (17).”
InfluentialSelf-citationZhao, Y. W., Atun, R. A., Anindya, K., McPake, B., Marthias, T., Pan, T., van Heusden, A., Zhang, P., Duolikun, N., & Lee, J. T. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004042 · Cited by 54
Exercise in people with comorbidity or multimorbidity.
Dekker, J., Buurman, B., & van der Leeden, M. (2019) · Health Psychology · doi:10.1037/hea0000750 · Cited by 47
Griffith, L. E., Gruneir, A., Fisher, K., Panjwani, D., Gafni, A., Patterson, C., Markle‐Reid, M., & Ploeg, J. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4149-3 · Cited by 56
The Ethics of Deprescribing in Older Adults
Reeve, E., Denig, P., Hilmer, S. N., & ter Meulen, R. (2016) · Journal of Bioethical Inquiry · doi:10.1007/s11673-016-9736-y · Cited by 50
Ramanathan, S. A., Hibbert, P. D., Wiles, L., Maher, C. G., & Runciman, W. B. (2018) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-018-2316-z · Cited by 54
Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions
Ouellet, G. M., Ouellet, J. A., & Tinetti, M. E. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618791371 · Cited by 53
Current guidelines poorly address multimorbidity: pilot of the interaction matrix method
Muth, C., Kirchner, H., van den Akker, M., Scherer, M., & Glasziou, P. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.07.004 · Cited by 47
“First, interactions were classified into the three accepted main categories: diseaseedisease (Di-Di-I), diseaseedrug (Di-D-I), and drugedrug interactions (DDI) [12].”
BackgroundGencer, B., Rodondi, N., Auer, R., Räber, L., Klingenberg, R., Nanchen, D., Carballo, D., Vogt, P., Carballo, S., Meyer, P., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.12.014 · Cited by 43
“Current guidelines do not address the challenges in the care of patients with mutlimorbidity, as well as the quality of evidence available for summarizing benefits and harms and formulating recommendations for this specific population [28].”
BackgroundA Change in Perspective: From Dual Diagnosis to Multimorbidity.
Bhalla, I. P., & Rosenheck, R. (2018) · Psychiatric Services · doi:10.1176/appi.ps.201700194 · Cited by 40
Multimorbidity and cardiovascular disease: a perspective on low- and middle-income countries
Thienemann, F., Ntusi, N. A. B., Battegay, E., Mueller, B. U., & Cheetham, M. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.09.09 · Cited by 34
“Limited evidence-based guidelines for MM (62), even for more prevalent forms of MM (60), enhances the reliance upon clinical guidelines that are intended for the treatment of single diseases (63).”
BackgroundTobacco and alcohol use disorders: evaluating multimorbidity
MacLean, R. R., Sofuoglu, M., & Rosenheck, R. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.11.006 · Cited by 39
The relationship of individual comorbid chronic conditions to diabetes care quality
Magnan, E. M., Palta, M., Mahoney, J., Pandhi, N., Bolt, D. M., Fink, J. T., Greenlee, R. T., & Smith, M. A. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000080 · Cited by 37
Ploeg, J., Yous, M., Fraser, K. D., Dufour, S. P., Baird, L. G., Kaasalainen, S., McAiney, C. A., & Markle‐Reid, M. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1345-2 · Cited by 51
Advancing multimorbidity management in primary care: a narrative review
Aramrat, C., Choksomngam, Y., Jiraporncharoen, W., Wiwatkunupakarn, N., Pinyopornpanish, K., Mallinson, P. A. C., Kinra, S., & Angkurawaranon, C. (2022) · Primary Health Care Research & Development · doi:10.1017/s1463423622000238 · Cited by 60
“A framework for the development of CPGs that consider multimorbidity has been developed (Uhlig et al., 2014), but CPGs regarding how to provide particular treatments given a particular set of multiple comorbidities are still limited (World Health Organization, 2016).”
BackgroundGoodman, R. A., Boyd, C. M., Tinetti, M. E., Kohorn, I. V., Parekh, A. K., & McGinnis, J. M. (2014) · The Annals of Family Medicine · doi:10.1370/afm.1646 · Cited by 44
Self-citationAshley, L., Surr, C., Kelley, R., Price, M. L., Griffiths, A. W., Fowler, N. R., Giza, D. E., Neal, R. D., Martin, C., Hopkinson, J. B., et al. (2022) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21767 · Cited by 33
“111‐113 Clinical practice guidelines have traditionally focused on single diseases, which greatly limits their utility in patients with comorbidities, especially those with multiple serious illnesses, who require care that is person‐centered rather than disease‐focused.(119,120) Moreover, clinical guidance should be e…”
BackgroundCaring for Patients With Multiple Chronic Conditions
Tinetti, M. E., Green, A. R., Ouellet, J. A., Rich, M. W., & Boyd, C. M. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3269 · Cited by 39
Self-citationGuthrie, B., Thompson, A., Dumbreck, S., Flynn, A., Alderson, P., Nairn, M., Treweek, S. P., & Payne, K. (2017) · Health Services and Delivery Research · doi:10.3310/hsdr05160 · Cited by 36
An integrated model of multimorbidity and symptom science
Tripp‐Reimer, T., Williams, J. K., Gardner, S. E., Rakel, B. A., Herr, K., McCarthy, A. M., Hand, L. L., Gilbertson‐White, S., & Cherwin, C. H. (2020) · Nursing Outlook · doi:10.1016/j.outlook.2020.03.003 · Cited by 35
“Finally, although professional societies have largely taken the responsibility for clinical practice guideline development, clinicians and investigators must be sensitized to the current deficits in the single disease focused guidelines, as well as the recommendations from AHRQ and professional societies about strateg…”
BackgroundBennett, W. L., Robbins, C. W., Bayliss, E. A., Wilson, R. F., Tabano, H., Mularski, R. A., Chan, W., Puhan, M. A., Yu, T., Leff, B. A., et al. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4039-5 · Cited by 31
Self-citationNorth, C. S., Brown, E. S., & Pollio, D. E. (2016) · Annals of Clinical Psychiatry · doi:10.1177/104012371602800307 · Cited by 34
“2,4,7,12,16,17 Most of the evidence informing the development of clinical practice guidelines has derived from research on patients with only 1 medical condition or disorder.”
Polypharmacy and Multimorbidity Among Medicaid Enrollees: A Multistate Analysis
Feng, X., Tan, X., Riley, B. L., Zheng, T., Bias, T. K., & Sambamoorthi, U. (2017) · Population Health Management · doi:10.1089/pop.2017.0065 · Cited by 39
“Current evidence-based clinical practice primarily follows single disease-specific treatment and prevention guidelines; however, this kind of practice paradigm may sometimes be detrimental and impractical for patients with multimorbidity.(4,5) For example, in Boyd et al, if all recommendations from the clinical practi…”
Spring, B. J., Stump, T. K., Penedo, F. J., Pfammatter, A. F., & Robinson, J. K. (2019) · Health Psychology · doi:10.1037/hea0000760 · Cited by 32
“Despite recent calls to update clinical guidelines to reflect the complexities of treating comorbidities (Arnett et al., 2014; Uhlig et al., 2014), the additional data collection needed and translation of research findings to practice probably will require more than a decade to accomplish (Morris,…”
BackgroundCharlson, M. E., & Wells, M. T. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000521952 · Cited by 25
Personalized Disease Screening Decisions Considering a Chronic Condition
Hajjar, A., & Alagöz, O. (2022) · Management Science · doi:10.1287/mnsc.2022.4336 · Cited by 24
Recommendations and quality of multimorbidity guidelines: a systematic review.
Wang, Z.-J., Zhu, D., Zhang, H.-Y., Wang, L., He, H.-F., Li, Z., Wang, B.-Y., Zhang, J., Li, X., Tuinhof, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102559 · Cited by 22
Mekonnen, A. B., Redley, B., Crawford, K., Jones, S., de Courten, B. V., & Manias, E. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2044786 · Cited by 21
“As such, interactions between the treatment of multiple conditions and outcomes may be ignored [7], especially when multiple prescribers are involved in treating a single patient.”
BackgroundPaukkonen, L., Oikarinen, A., Kähkönen, O., & Kyngäs, H. A. (2021) · Health Expectations · doi:10.1111/hex.13306 · Cited by 23
Guidance on guidelines: Understanding the evidence on the uptake of health care guidelines
Brennan, C. A., Greenhalgh, J., & Pawson, R. (2017) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12734 · Cited by 29
“We turn to the next adaptation, theory 1b, namely, to increase attention to comorbidity within condition specific guidelines.(36,37,42,43) Here, the idea is that guidelines should provide information to enable clinicians to more effectively apply the guideline to patients with multimorbidity; for example, by detailing…”
BackgroundThe HHS Strategic Framework on Multiple Chronic Conditions: Genesis and Focus on Research
Parekh, A. K., & Goodman, R. A. (2013) · Journal of Comorbidity · doi:10.15256/joc.2013.3.20 · Cited by 20
Evidence-Based Medicine and the Hard Problem of Multimorbidity
Boyd, C. M., & Kent, D. M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2658-z · Cited by 69
Self-citationLu, L., Yao, K., Chen, J., Yang, Y., Wang, K., Zheng, J., Guo, P., Cai, Y., & Zhang, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.995948 · Cited by 21
“The association between number of drugs and PIMs used is probably confounded by the number and types of comorbidities (7, 8).”
BackgroundWhole person care, patient-centred care and clinical practice guidelines in general practice
Hansen, E., Walters, J., & Howes, F. (2016) · Health Sociology Review · doi:10.1080/14461242.2016.1170625 · Cited by 21
“This shortcoming of CPGs has resulted in calls for the formulation of CPGs for people with co-morbidities/multimorbidities (Uhlig et al., 2014).”
BackgroundRoberts, E. R., Green, D. J., & Kadam, U. T. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005429 · Cited by 24
Wahed, A. A. A., El-Dahiyat, F., Aljawamis, D. F., Ajimi, J. A., & Rafeea, K. J. B. (2021) · International journal of clinical practice · doi:10.1111/ijcp.14715 · Cited by 19
Lai, F. T. T., Beeler, P. E., Yip, B. H. K., Cheetham, M., Chau, P. Y. K., Chung, R. Y., Wong, E. L., Yeoh, E., Battegay, E. J., & Wong, S. Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.651925 · Cited by 22
Alimohammadian, M., Majidi, A., Yaseri, M., Ahmadi, B., Islami, F., Derakhshan, M. H., Delavari, A., Amani, M., Feyz-Sani, A., Poustchi, H., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013548 · Cited by 105
New horizons in clinical practice guidelines for use with older people
Martin, F. C., Quinn, T. J., Straus, S. E., Anand, S. S., van der Velde, N., & Harwood, R. (2024) · Age and Ageing · doi:10.1093/ageing/afae158 · Cited by 18
“Most CPGs for chronic conditions focus on one disease [5], but considering any of these in isolation is likely to be inadequate as adults living with two or more long-term conditions outnumber those living with one, and multi-morbidity incidence increases with age [15].”
Integrated Care for Multimorbidity Population in Asian Countries: A Scoping Review
Lin, J., Islam, M. K., Leeder, S., Huo, Z., Hung, C. T., Yeoh, E., Gillespie, J., Dong, H., Askildsen, J. E., Liu, D., et al. (2022) · International Journal of Integrated Care · doi:10.5334/ijic.6009 · Cited by 18
Defining Multiple Chronic Conditions for Quality Measurement
Drye, E. E., Altaf, F. K., Lipska, K. J., Spatz, E. S., Montague, J. A., Bao, H., Parzynski, C. S., Ross, J. S., Bernheim, S. M., Krumholz, H. M., et al. (2017) · Medical Care · doi:10.1097/mlr.0000000000000853 · Cited by 16
Zou, S., Wang, Z., Bhura, M., & Tang, K. (2020) · Public Health · doi:10.1016/j.puhe.2022.01.021 · Cited by 25
Sever, S., Golder, S., & Doherty, P. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0974-2 · Cited by 16
Addressing Multimorbidity in Evidence Integration and Synthesis
Trikalinos, T. A., Segal, J. B., & Boyd, C. M. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2661-4 · Cited by 16
Self-citationPrevalence and overlap of Disease Management Program diseases in older hospitalized patients
Juul‐Larsen, H. G., Petersen, J., Sivertsen, D. M., & Andersen, O. (2017) · European Journal of Ageing · doi:10.1007/s10433-017-0412-9 · Cited by 13
“…societies and researchers around the world have started developing guidelines or DMPs for older patients with multimorbidity (Fabbri et al. 2012; Uhlig et al. 2014; Weiss et al. 2014; Bernabeu-Wittel et al. 2014), but the complexity of the different treatment regimens and the interactions…”
BackgroundTrustworthy evidence-based versus untrustworthy guidelines: detecting the difference
Lima, J. P., Tangamornsuksan, W., & Guyatt, G. H. (2023) · Family Medicine and Community Health · doi:10.1136/fmch-2023-002437 · Cited by 16
Self-citationLentz, T. A., Hellkamp, A. S., Bhavsar, N. A., Goode, A. P., Manhapra, A., & George, S. Z. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.09.011 · Cited by 20
Clinical Guidelines in the Context of Aging and Multimorbidity
Guthrie, B., & Boyd, C. M. (2018) · Public Policy & Aging Report · doi:10.1093/ppar/pry038 · Cited by 17
“Active and explicit consideration of comorbidity and the consequences of aging at each step of guideline development is the core way in which single-disease guidelines could be improved, and there are published frameworks to guide this (Figure 3; Uhlig et al., 2014).”
BackgroundSelf-citationUse of surrogate outcomes in US FDA drug approvals, 2003–2012: a survey
Yu, T., Hsu, Y.-J., Fain, K. M., Boyd, C., Holbrook, J., & Puhan, M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007960 · Cited by 12
Self-citationShared decision making for people living with multimorbidity: A concept analysis.
Shi, S., Liu, X.-Z., Li, Y., & Yang, C. (2025) · Patient Education and Counseling · doi:10.1016/j.pec.2025.108712 · Cited by 11
Generalizability of Results from Randomized Controlled Trials in Post-Stroke Physiotherapy
Paci, M., Prestera, C., & Ferrarello, F. (2020) · Physiotherapy Canada · doi:10.3138/ptc-2018-0117 · Cited by 15
Determinants of depression in patients with comorbid depression following cardiac rehabilitation
Sever, S., Harrison, A. S., Golder, S., & Doherty, P. (2019) · Open Heart · doi:10.1136/openhrt-2018-000973 · Cited by 11
“Due to increased survival rates in CVD and an ageing population, there has been an increase in the number of comorbidities present with CVD which further complicates the management of a patient’s condition and service delivery options.(4) Depression is reported to be a prevalent comorbidity in cardiac patients; the pr…”
BackgroundClinical practice guidelines adaptation for internists - An EFIM methodology
Leśniak, W., Morbidoni, L., Dicker, D., & Marin-Leon, I. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.016 · Cited by 12
Multimorbidity in health psychology and behavioral medicine.
Suls, J. M., & Green, P. A. (2019) · Health Psychology · doi:10.1037/hea0000783 · Cited by 13
Future Research Directions for Multimorbidity Involving Cardiovascular Diseases
Salive, M. E. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.01.008 · Cited by 8
A Novel Approach to Developing a Discordance Index for Older Adults With Chronic Kidney Disease
Hall, R. K., Zhou, H. C., Reynolds, K., Harrison, T. N., & Bowling, C. B. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz248 · Cited by 12
“The traditional approach to caring for patients with chronic disease is particularly challenging because most CPGs focus on management of a single condition and its related concordant conditions and not the spectrum of comorbidities that often coexist (2).”
BackgroundHerzig, L., Mueller, Y. K., Haller, D. M., Zeller, A., Neuner‐Jehle, S., Déruaz‐Luyet, A., Cohidon, C., Streit, S., Burnand, B., & Zuchuat, J.-C. (2019) · BJGP Open · doi:10.3399/bjgpopen18x101622 · Cited by 10
“They must therefore try to set medical priorities, as the co-management of every condition present during the same consultation is often impossible.(17) FPs are trained to focus first on the clinical problems which pose the highest risk of mortality or morbidity to the patient (such as heart diseases and diabetes), an…”
BackgroundComorbidity Subgroups Among Medicare Beneficiaries Seeking Health Care for Musculoskeletal Pain
Lentz, T. A., Marlow, N. M., Beneciuk, J. M., Fillingim, R. B., & George, S. Z. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly202 · Cited by 10
Engelmann, P., Eilerskov, N., Thilsing, T., Bernardini, F., Rasmussen, S., Löwe, B., Herrmann-Lingen, C., Gostoli, S., Andréasson, F., Rafanelli, C., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1186390 · Cited by 7
Nelson, M. L. A., Singh, H., Nie, J. X., MacDonald, S. L., Bayley, M. T., Fortin, C. D., & Upshur, R. E. G. (2023) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565231211668 · Cited by 5
“10,11 In previously published work, stroke rehabilitation clinicians have questioned the applicability of stroke rehabilitation clinical guidelines to their ‘ real-world patients, ’ as the high quality evidence that underpins these guidelines often exclude patients on the basis of age, history of…”
BackgroundEliminating medication overload: A national action plan
Working Group on Medication Overload (2020) · doi:10.46241/li.ylbw4885 · Cited by 4
Methodology for senior‐proof guidelines: A practice example from the Netherlands
van Munster, B. V., Portielje, J. E., Maier, A., Arends, A., & de Beer, J. (2018) · Journal of Evaluation In Clinical Practice · doi:10.1111/jep.12738 · Cited by 7
“The framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity of Uhlig was used as a useful example for the topics that had to be taken into account.(8) Two stages of guideline development were distinguished: the preparation stage and the development…”
Method
Metadata
- Authors
- Uhlig, K., Leff, B., Kent, D., Dy, S., Brunnhuber, K., Burgers, J. S., Greenfield, S., Guyatt, G., High, K., Leipzig, R., Mulrow, C., Schmader, K., Schunemann, H., Walter, L. C., Woodcock, J., & Boyd, C. M.
- Affiliations
- Tufts University (US)
- Johns Hopkins University (US)
- Tufts Medical Center (US)
- BMJ Group (United Kingdom) (GB)
- Dutch College of General Practitioners (NL)
- University of California, Irvine (US)
- McMaster University (CA)
- Wake Forest University Health Sciences (US)
- Icahn School of Medicine at Mount Sinai (US)
- The University of Texas at San Antonio Health Science Center (US)
- Duke Medical Center (US)
- San Francisco VA Medical Center (US)
- University of Cambridge (GB)
- Corresponding author
- Boyd, Cynthia M.
- ORCID
- Venue
- Journal of General Internal Medicine
- Published
- 2014-01-18
- Volume
- 29
- Issue
- 4
- Pages
- 670-679
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- PMC
- PMC3965742
- OpenAlex
- W2146328920
- Cited by
- 158
- References
- 0
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 12 · 2021: 9 · 2020: 10 · 2019: 18 · 2018: 13 · 2017: 22 · 2016: 18 · 2015: 14 · 2014: 10
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of General Internal Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Robert Wood Johnson Foundation
- John A. Hartford Foundation
- Hartford Foundation for Public Giving
- Atlantic Philanthropies
- Brown University
- Tufts Medical Center
- Johns Hopkins University
- Starr Foundation
- Agency for Healthcare Research and Quality (R21HS017653, R21HS018597, AHRQ R21 HS017653, AHRQ R21 HS018597-01)
- Johns Hopkins Bloomberg School of Public Health
- Medical Research Council (MR/K021796/1, MR/K023187/1)
- Economic and Social Research Council (ES/G007462/1)
- Center for Innovative Medicine
- National Institute on Aging (K23AG032910, K24AG041180, NIA K23 AG032910, P30AG028716)
- National Cancer Institute (R01CA134425)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- multimorbidity, guideline development, comorbidities, clinical decision-making, guideline applicability, evidence quality assessment, benefit-harm assessment, consensus recommendations, stakeholder engagement
- MeSH terms
- Congresses as Topic, Patient Care, Humans, Comorbidity, Practice Guidelines as Topic, Evidence-Based Medicine, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
